Symmetry Medical Earnings Preview

While Symmetry Medical (NYSE: SMA  ) missed estimates last quarter, investors hope that it will bounce back and outpace Wall Street expectations this quarter. The company will unveil its latest earnings on Thursday, Feb. 23. Symmetry Medical is an independent provider of implants, related instruments, and cases to global orthopedic device manufacturers.

What analysts say:

  • Buy, sell, or hold?: Analysts strongly back Symmetry Medical, with four of five rating it a buy and the remainder rating it a hold. Analysts like Symmetry Medical better than competitor RTI Biologics overall. Analysts still rate the stock a moderate buy, but they are a bit more wary about it compared to three months ago.
  • Revenue forecasts: On average, analysts predict $80.8 million in revenue this quarter. That would represent a decline of 15.8% from the year-ago quarter.
  • Wall Street earnings expectations: The average analyst estimate is earnings of $0.04 per share. Estimates range from $0.03 to $0.07.

What our community says:
CAPS All Stars are strongly backing the stock, with 87% assigning it an "outperform" rating. Most of the community backs the All Stars, with 89.5% giving it a rating of "outperform." Despite the majority sentiment in favor of Symmetry Medical, the stock has a middling CAPS rating of three out of five stars.

A year-over-year revenue decrease last quarter snaps a streak of three consecutive quarters of revenue increases. The company's gross margin shrank by 2.9 percentage points in the last quarter. Revenue fell 8.2%, while cost of sales fell 4.8% to $68.3 million from a year earlier.

Now let's look at how efficiently management is running the business. Margins are a representation of how efficiently a company captures portions of sales dollars. Symmetry Medical has seen a slipping net margin year-over-year for the last three quarters. Net margin reflects what percentage of each dollar earned by the company becomes profit. See how Symmetry Medical has been doing for the last four quarters:






Gross Margin





Operating Margin





Net Margin





We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Symmetry Medical now.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Earnings estimates provided by Zacks.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1783955, ~/Articles/ArticleHandler.aspx, 10/27/2016 6:38:23 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.68 -29.65 -0.16%
S&P 500 2,133.04 -6.39 -0.30%
NASD 5,215.97 -34.29 -0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
SMA.DL $0.00 Down +0.00 +0.00%
Symmetry Medical CAPS Rating: No stars